Search
Search Results
##search.searchResults.foundPlural##
-
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3296PDF: 1241HTML: 2188Fi.1 Gritti.Rambaldi: 184 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3813PDF: 1432HTML: 9169Untitled: 255Untitled: 158Untitled: 148Untitled: 143Untitled: 162Untitled: 315 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
668PDF: 462Suppl. Files: 104HTML: 75 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
2151PDF: 918HTML: 56 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
1932PDF: 573Suppl. Files: 265HTML: 150 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1457PDF: 716HTML: 2105Untitled: 175Untitled: 166Untitled: 179Untitled: 162Untitled: 178 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2459PDF: 920HTML: 2214 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1406PDF: 531HTML: 198 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2396PDF: 757HTML: 1720 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4070PDF: 1696HTML: 457Figure 1: Age distribution of Pediatric cases: 192 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2347HTML: 9374DOCX: 973Tables Dengue: 190 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3117PDF: 743HTML: 2912Figure 1a and 1b: 133Figure 2: 136Figure 3: 158Figure 4: 142Figure 5: 144Tables 1-5: 140 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
800PDF: 477HTML: 1282 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4142PDF: 1120HTML: 2118Figure 1: 144 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1108PDF: 798HTML: 2163Figue 1: 157 -







